texans teaming up

Houston startup teams up with Austin company on medical device amid COVID-19 crisis

Houston-based Galen Data is collaborating with an Austin health device company on a cloud-based platform that monitors vital signs. Photo via galendata.com

Two Texas companies with NASA roots are joining forces on a technology that can be used to monitor vital signs of seniors or others that are at-risk of contracting COVID-19.

Houston-based Galen Data Inc., which has developed a cloud platform for medical devices, and Austin-based Advanced TeleSensors Inc., the creator of the Cardi/o touchless monitor. Together, the two health tech companies are collaborating to take ATS's device and adding Galen Data's cloud technology.

"We wish we had found Galen Data sooner. We had been building our own cloud for six months, thinking a custom solution would best meet our needs," says Sajol Ghoshal, CEO and president of ATS, in a news release. "Getting up-and-running with them was very easy, and it allowed us to focus on our core competency — which is data-signal processing."

ATS's technology uses radio frequency in its remote, touchless monitoring. The company's founders developed the core technology at NASA's Jet Propulsion Lab. Initially, the technology was intended for assisted living facilities. Now, amid the COVID-19 crisis, monitoring isolated seniors or at-risk patients is even more relevant.

Galen Data, which launched in 2016, also has NASA roots as the founders met as software contractors working on NASA's safety systems. The company has developed and marketed its cloud-based platform for connecting medical devices to the internet, including pacemakers and glucose monitors.

Chris DuPont, co-founder and CEO, has led the company to meet compliance standards set by the U.S. Food and Drug Administration (FDA), the Health Insurance Portability and Accountability Act of 1996 (HIPPA), cybersecurity organizations, and others.

"We knew that our platform would be a great fit for Cardi/o," Chris DuPont, CEO of Galen Data, says. "Speed was critical, accentuated by the COVID-19 crisis. We were well positioned to address ATS' needs, and help those at-risk in the process."

Sajol Ghoshal (left), CEO and president of ATS, and Chris Dupont, (CEO of Galen Data), are bringing together their technologies. Photos courtesy

Trending News

Building Houston

 
 

A Rice University team of engineers designed a low-cost ventilator, and now the device, which has been picked up for manufacturing, has received approval from the FDA. Photo courtesy of Jeff Fitlow/Rice University

A ventilator that was designed by a team at Rice University has received Emergency Use Authorization from the U.S. Food and Drug Administration amid the COVID-19 pandemic.

The ApolloBVM was worked on March by students at Rice's Brown School of Engineering's Oshman Engineering Design Kitchen, or OEDK. The open-source plans were shared online so that those in need could have access to the life-saving technology. Since its upload, the ApolloBVM design has been downloaded by almost 3,000 registered participants in 115 countries.

"The COVID-19 pandemic pushed staff, students and clinical partners to complete a novel design for the ApolloBVM in the weeks following the initial local cases," says Maria Oden, a teaching professor of bioengineering at Rice and director of the OEDK, in the press release. "We are thrilled that the device has received FDA Emergency Use Authorization."

While development began in 2018 with a Houston emergency physician, Rohith Malya, Houston manufacturer Stewart & Stevenson Healthcare Technologies LLC, a subsidiary of Kirby Corporation that licensed ApolloBVM in April, has worked with the team to further manufacture the device into what it is today.

An enhanced version of the bag valve mask-based ventilator designed by Rice University engineers has won federal approval as an emergency resuscitator for use during the COVID-19 pandemic. Photo courtesy of Stewart & Stevenson

The Rice team worked out of OEDK throughout the spring and Stewart & Stevenson joined to support the effort along with manufacturing plants in Oklahoma City and Houston.

"The FDA authorization represents an important milestone achievement for the Apollo ABVM program," says Joe Reniers, president of Kirby Distribution and Services, in the release. "We can now commence manufacturing and distribution of this low-cost device to the front lines, providing health care professionals with a sturdy and portable ventilation device for patients during the COVID-19 pandemic."

Reniers continues, "It is a testimony to the flexibility of our people and our manufacturing facilities that we are able to readily utilize operations to support COVID-19 related need."

The device's name was selected as a tribute to Rice's history with NASA and President John F. Kennedy's now-famous speech kicking off the nation's efforts to go to the moon. It's meaningful to Matthew Wettergreen, one of the members of the design team.

"When a crisis hits, we use our skills to contribute solutions," Wettergreen previously told CultureMap. "If you can help, you should, and I'm proud that we're responding to the call."

Trending News